Dihydromaniwamycin E, a Heat-Shock Metabolite from Thermotolerant <i>Streptomyces</i> sp. JA74, Exhibiting Antiviral Activity against Influenza and SARS-CoV-2 Viruses-Reference-Cited by-同舟云学术

Dihydromaniwamycin E, a Heat-Shock Metabolite from Thermotolerant Streptomyces sp. JA74, Exhibiting Antiviral Activity against Influenza and SARS-CoV-2 Viruses

Published:2022-10-12 Issue:11 Volume:85 Page:2583-2591
ISSN:0163-3864
Container-title:Journal of Natural Products
language:en
Short-container-title:J. Nat. Prod.

Author:

Saito Shun¹,Funayama Kayo¹,Kato Wataru¹,Okuda Mayu¹,Kawamoto Meiko¹,Matsubara Teruhiko¹^ORCID,Sato Toshinori¹^ORCID,Sato Akihiko²³,Otsuguro Satoko⁴,Sasaki Michihito³,Orba Yasuko³⁵,Sawa Hirofumi³⁵⁶⁷,Maenaka Katsumi⁴,Shindo Kazutoshi⁸^ORCID,Imoto Masaya⁹,Arai Midori A.¹^ORCID

Affiliation:

1. Department of Biosciences and Informatics, Faculty of Science and Technology, Keio University, Yokohama 223-8522, Japan

2. Drug Discovery and Disease Research Laboratory, Shionogi & Co., Ltd., Osaka 541-0045, Japan

3. Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo 001-0020, Japan

4. Laboratory of Biomolecular Science, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan

5. International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo 001-0020, Japan

6. One Health Research Center, Hokkaido University, Sapporo 060-0818, Japan

7. Global Virus Network, Baltimore, Maryland 21201, United States

8. Department of Food and Nutrition, Japan Women’s University, Tokyo 112-8681, Japan

9. Department of Neurology, Juntendo University School of Medicine, Tokyo 113-8431, Japan

Funder

Naito Foundation

Institute for Fermentation, Osaka

Japan Agency for Medical Research and Development

Tokyo Biochemical Research Foundation

Japan Society for the Promotion of Science

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,Analytical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jnatprod.2c00550

Reference24 articles.

1. Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019

2. Microbial drug discovery: 80 years of progress

3. Genome Sequence of the Streptomycin-Producing Microorganism Streptomyces griseus IFO 13350

4. Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2)

5. Genome mining of the Streptomyces avermitilis genome and development of genome-minimized hosts for heterologous expression of biosynthetic gene clusters

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptionally induced nucleoid-associated protein-like ccr1 in combined-culture serves as a global effector of Streptomyces secondary metabolism;Frontiers in Microbiology;2024-07-12

2. Methodology for awakening the potential secondary metabolic capacity in actinomycetes;Beilstein Journal of Organic Chemistry;2024-04-10

3. Bioactive Metabolites from Terrestrial and Marine Actinomycetes;Molecules;2023-08-06